Mara Renewables has secured USD$9.1 million in funding from S2G Investments to expand its sustainable, algae-based omega-3 platform and enhance its research and development efforts.

Information on the Target

Mara Renewables Corporation, headquartered in Halifax, Nova Scotia, is a pioneering biotechnology firm specializing in algae-based nutritional solutions for both human and animal consumption. The company focuses on providing premium, fish-free omega-3 fatty acids, particularly DHA, aimed at enhancing overall health through innovative and sustainable practices.

With a commitment to environmental sustainability, Mara employs cutting-edge techniques in precision fermentation to cultivate microalgae, ensuring a reliable and high-quality supply of omega-3s. This process not only addresses critical nutritional gaps but also minimizes the ecological impact related to traditional fish-based omega-3 sourcing.

Industry Overview in Canada

The omega-3 market in Canada is experiencing significant growth, fueled by increased consumer awareness of health and nutrition. Omega-3 fatty acids play a crucial role in numerous health aspects, includi

View Source

Similar Deals

Pathway to Cures SeraGene Therapeutics

2025

Other VC Bio Therapeutic Drugs Canada
Malar Group EverKind

2025

Other VC Healthcare Facilities & Services (NEC) Canada
Pycap SMYLS

2025

Other VC Doctor's Office Canada
Pycap ChargerQuest

2024

Other VC Alternative Medicine Facilities Canada
Sun Life Canada Dialogue

2023

Other VC Telemedicine Services Canada
TVM Capital Life Science Esperas Pharma, Inc.

2023

Other VC Bio Therapeutic Drugs Canada

S2G Investments

invested in

Mara Renewables

in 2025

in a Other VC deal

Disclosed details

Transaction Size: $9M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert